Christopher Lemmon, MD

Summary

My research is focused on advancing experimental therapeutics, precision oncology, and biomarker-driven treatment strategies through both investigator-initiated and multicenter clinical trials to improve outcomes for patients with lung cancer and other thoracic malignancies. I serve as site principal investigator and collaborator on numerous national and industry-sponsored studies and have led or collaborated on several investigator-initiated studies contributing to the development of next-generation treatment approaches. Additional research interests involve process improvement modeling for clinical outcomes and cost effectiveness.